Adial Pharmaceuticals Future Growth
Future criteria checks 0/6
Adial Pharmaceuticals is forecast to grow earnings and revenue by 6.2% and 94% per annum respectively while EPS is expected to grow by 50.5% per annum.
Key information
6.2%
Earnings growth rate
50.5%
EPS growth rate
Pharmaceuticals earnings growth | 23.7% |
Revenue growth rate | 94.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Adial Clinical Trial: A Fluff Or A Win?
Aug 22Adial Pharmaceuticals GAAP EPS of -$0.16 beats by $0.01
Aug 16Revisiting Adial Pharmaceuticals: EMA Approval For Alcohol Use Disorder Pill Is A Critical Catalyst
Jun 21Adial Pharmaceuticals shares +5% on receiving third patent for opioid use disorder candidate
Jan 11Adial Pharmaceuticals inks stock purchase agreement with Keystone Capital
Nov 25Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -16 | N/A | N/A | 2 |
12/31/2025 | N/A | -9 | N/A | N/A | 3 |
12/31/2024 | N/A | -13 | N/A | N/A | 3 |
9/30/2024 | N/A | -13 | -7 | -7 | N/A |
6/30/2024 | N/A | -12 | -6 | -6 | N/A |
3/31/2024 | N/A | -11 | -6 | -6 | N/A |
12/31/2023 | N/A | -7 | -7 | -7 | N/A |
9/30/2023 | N/A | -8 | -7 | -7 | N/A |
6/30/2023 | N/A | -9 | -9 | -9 | N/A |
3/31/2023 | N/A | -10 | -11 | -11 | N/A |
12/31/2022 | N/A | -11 | -11 | -11 | N/A |
9/30/2022 | N/A | -14 | -12 | -12 | N/A |
6/30/2022 | N/A | -16 | -12 | -12 | N/A |
3/31/2022 | N/A | -17 | -12 | -12 | N/A |
12/31/2021 | N/A | -19 | -12 | -12 | N/A |
9/30/2021 | N/A | -17 | -12 | -12 | N/A |
6/30/2021 | N/A | -16 | -11 | -11 | N/A |
3/31/2021 | N/A | -13 | -9 | -9 | N/A |
12/31/2020 | N/A | -11 | -8 | -8 | N/A |
9/30/2020 | N/A | -9 | -7 | -7 | N/A |
6/30/2020 | N/A | -8 | -6 | -6 | N/A |
3/31/2020 | N/A | -8 | -6 | -6 | N/A |
12/31/2019 | N/A | -9 | -6 | -6 | N/A |
9/30/2019 | N/A | -8 | -6 | -6 | N/A |
6/30/2019 | N/A | -14 | -5 | -5 | N/A |
3/31/2019 | N/A | -14 | -4 | -4 | N/A |
12/31/2018 | N/A | -12 | -2 | -2 | N/A |
9/30/2018 | N/A | -11 | -2 | -2 | N/A |
6/30/2018 | N/A | -3 | N/A | -1 | N/A |
3/31/2018 | N/A | -1 | N/A | -1 | N/A |
12/31/2017 | N/A | -1 | N/A | 0 | N/A |
9/30/2017 | N/A | -1 | N/A | 0 | N/A |
6/30/2017 | N/A | -1 | N/A | 0 | N/A |
3/31/2017 | N/A | 0 | N/A | 0 | N/A |
12/31/2016 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ADIL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ADIL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ADIL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ADIL is forecast to have no revenue next year.
High Growth Revenue: ADIL is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ADIL's Return on Equity is forecast to be high in 3 years time